Skip to main content
TipRanks
Go Ultimate75% OFF

PF Equity Holdings 2 B.V. Insider Profile

4 Followers

PF Equity Holdings 2 B.V., Ten Percent Owner at Allogene Therapeutics, holds 0.00 shares in Allogene Therapeutics (Ticker: ALLO).

PF Equity Holdings 2 B.V.'s Trading History

ALLO
Allogene Therapeutics
Apr 04, 2022Ten Percent OwnerUninformative Sell―$0.00
ALLO
Insider Shares: 0.00 (0.00%)

PF Equity Holdings 2 B.V. has not reported any informative transactions for ALLO, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 04, 2022Uninformative Sell$0.0022,032,040$0.00―

You May Also Like

PF Equity Holdings 2 B.V. insider profile FAQ

What stocks does PF Equity Holdings 2 B.V. hold?
PF Equity Holdings 2 B.V. holds: ALLO stocks.
What is PF Equity Holdings 2 B.V.'s role in Allogene Therapeutics?
PF Equity Holdings 2 B.V.'s role in Allogene Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.